These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 2760211)
21. A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo. Haq M; Kremer R; Goltzman D; Rabbani SA J Clin Invest; 1993 Jun; 91(6):2416-22. PubMed ID: 8514854 [TBL] [Abstract][Full Text] [Related]
22. Effects of calcitriol, 22-oxacalcitriol, and calcipotriol on serum calcium and parathyroid hormone gene expression. Naveh-Many T; Silver J Endocrinology; 1993 Dec; 133(6):2724-8. PubMed ID: 8243296 [TBL] [Abstract][Full Text] [Related]
23. Differential effects of 1,25-dihydroxy-vitamin D3 and 19-nor-1,25-dihydroxy-vitamin D2 on calcium and phosphorus resorption in bone. Finch JL; Brown AJ; Slatopolsky E J Am Soc Nephrol; 1999 May; 10(5):980-5. PubMed ID: 10232683 [TBL] [Abstract][Full Text] [Related]
24. The activity of 22-oxacalcitriol in osteoblast-like (ROS 17/2.8) cells. Pernalete N; Mori T; Nishii Y; Slatopolsky E; Brown AJ Endocrinology; 1991 Aug; 129(2):778-84. PubMed ID: 1649745 [TBL] [Abstract][Full Text] [Related]
25. A comparison between 1,25-dihydroxy-22-oxavitamin D(3) and 1,25-dihydroxyvitamin D(3) regarding suppression of parathyroid hormone secretion and calcaemic action. Hirata M; Endo K; Katsumata K; Ichikawa F; Kubodera N; Fukagawa M Nephrol Dial Transplant; 2002; 17 Suppl 10():41-5. PubMed ID: 12386268 [TBL] [Abstract][Full Text] [Related]
26. Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat. Silver J; Naveh-Many T; Mayer H; Schmelzer HJ; Popovtzer MM J Clin Invest; 1986 Nov; 78(5):1296-301. PubMed ID: 3771798 [TBL] [Abstract][Full Text] [Related]
27. Differential effects of 1,25-(OH)2D3 and 22-oxacalcitriol on phosphate and calcium metabolism. Finch JL; Brown AJ; Kubodera N; Nishii Y; Slatopolsky E Kidney Int; 1993 Mar; 43(3):561-6. PubMed ID: 8455354 [TBL] [Abstract][Full Text] [Related]
28. Effects of i.v. and oral 1,25-dihydroxy-22-oxavitamin D(3) on secondary hyperparathyroidism in dogs with chronic renal failure. Takahashi F; Furuichi T; Yorozu K; Kawata S; Kitamura H; Kubodera N; Slatopolsky E Nephrol Dial Transplant; 2002; 17 Suppl 10():46-52. PubMed ID: 12386269 [TBL] [Abstract][Full Text] [Related]
29. Regulation of synthesis and secretion of chromogranin-A by calcium and 1,25-dihydroxycholecalciferol in cultured bovine parathyroid cells. Mouland AJ; Hendy GN Endocrinology; 1991 Jan; 128(1):441-9. PubMed ID: 1986936 [TBL] [Abstract][Full Text] [Related]
30. A comparison between daily and thrice-weekly i.v. administration of 1,25-dihydroxy-22-oxavitamin D(3) regarding suppression of parathyroid hormone secretion and calcaemic action in uraemic rats. Hirata M; Endo K; Ohkawa H; Kumaki K; Kubodera N; Slatopolsky E; Kurokawa K; Fukagawa M Nephrol Dial Transplant; 2002; 17 Suppl 10():37-40. PubMed ID: 12386267 [TBL] [Abstract][Full Text] [Related]
31. The vitamin D prodrugs 1alpha(OH)D2, 1alpha(OH)D3 and BCI-210 suppress PTH secretion by bovine parathyroid cells. Brown AJ; Ritter CS; Knutson JC; Strugnell SA Nephrol Dial Transplant; 2006 Mar; 21(3):644-50. PubMed ID: 16221703 [TBL] [Abstract][Full Text] [Related]
32. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients. Slatopolsky E; Weerts C; Thielan J; Horst R; Harter H; Martin KJ J Clin Invest; 1984 Dec; 74(6):2136-43. PubMed ID: 6549016 [TBL] [Abstract][Full Text] [Related]
33. Opposite effects of 1,25(OH)2D3 on synthesis and release of PTH compared with secretory protein I. Ridgeway RD; MacGregor RR Am J Physiol; 1988 Mar; 254(3 Pt 1):E279-86. PubMed ID: 3348388 [TBL] [Abstract][Full Text] [Related]
34. Metabolism of 22-oxacalcitriol by a vitamin D-inducible pathway in cultured parathyroid cells. Brown AJ; Berkoben M; Ritter C; Kubodera N; Nishii Y; Slatopolsky E Biochem Biophys Res Commun; 1992 Dec; 189(2):759-64. PubMed ID: 1472047 [TBL] [Abstract][Full Text] [Related]
35. Calcium receptor messenger ribonucleic acid levels in the parathyroid glands and kidney of vitamin D-deficient rats are not regulated by plasma calcium or 1,25-dihydroxyvitamin D3. Rogers KV; Dunn CK; Conklin RL; Hadfield S; Petty BA; Brown EM; Hebert SC; Nemeth EF; Fox J Endocrinology; 1995 Feb; 136(2):499-504. PubMed ID: 7835282 [TBL] [Abstract][Full Text] [Related]
36. Combined effects of dexamethasone and 1,25-dihydroxyvitamin D3 on parathyroid hormone secretion in cultured bovine parathyroid cells. Sugimoto T; Brown AJ; Ritter C; Morrissey J; Slatopolsky E; Martin KJ Endocrinology; 1989 Aug; 125(2):638-41. PubMed ID: 2546741 [TBL] [Abstract][Full Text] [Related]
37. Effects of vitamin D3, 25-hydroxyvitamin D3, and 24,25-dihydroxyvitamin D3 on parathyroid hormone secretion. Cantley LK; Russell JB; Lettieri DS; Sherwood LM Calcif Tissue Int; 1987 Jul; 41(1):48-51. PubMed ID: 3040201 [TBL] [Abstract][Full Text] [Related]
38. The effect of 1,25 dihydroxycholecalciferol on parathyroid hormone secretion by monolayer cultures of bovine parathyroid cells. Chan YL; McKay C; Dye E; Slatopolsky E Calcif Tissue Int; 1986 Jan; 38(1):27-32. PubMed ID: 3079648 [TBL] [Abstract][Full Text] [Related]
39. 22-Oxacalcitriol, a noncalcemic analogue of calcitriol, suppresses both cell proliferation and parathyroid hormone-related peptide gene expression in human T cell lymphotrophic virus, type I-infected T cells. Inoue D; Matsumoto T; Ogata E; Ikeda K J Biol Chem; 1993 Aug; 268(22):16730-6. PubMed ID: 8393873 [TBL] [Abstract][Full Text] [Related]
40. Comparison of the efficacy of an oral calcitriol pulse or intravenous 22-oxacalcitriol therapies in chronic hemodialysis patients. Tamura S; Ueki K; Mashimo K; Tsukada Y; Naitoh M; Abe Y; Kawai H; Tsuchida A; Wakamatsu R; Nojima Y Clin Exp Nephrol; 2005 Sep; 9(3):238-43. PubMed ID: 16189633 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]